Skip to content

A clinical study of anti-aging effect for test product

A clinical study of anti-aging effect for test product - A clinical study of anti-aging effect for test product

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048899
Enrollment
22
Registered
2022-09-09
Start date
2021-09-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

The participants apply the cream containing 1.5% porcine placental extract. The treatment is applied to the participants&#39
whole face, except for the non-treated side of the crow&#39
s feet, twice a day in the morning and evening for 8 weeks.

Sponsors

DHC Corporation Primary Research Unit Primary Research Group 1
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Korean female participants aged between 40 and 60 with wrinkle on their crow's feet and nasolabial fold; subjects who sign the informed consent of the study; and those who are cooperative and available for follow-up during the study period.

Exclusion criteria

Exclusion criteria: participants who are pregnant, in nursing condition, or planning to become pregnant; participants who are treated with immune-suppressant within one month from the conduct of the study; participants who participated in a previous study without an appropriate intervening period of one month between studies; participants who have sensitive or hypersensitive skin; participants who have damaged skin in or around the test site, which includes sunburn, tattoos, scars, or other disfiguration on the test site; participants who used similar treatment related to the study during the previous three months; participants who had an experience on test site (skin microdermabrasion, Botox and other skin treatment); participants who have chronic disease (diabetes, asthma, or high blood-pressure); participants who have atopic dermatitis; and participants who have any problem, which might interfere with the healing process.

Design outcomes

Primary

MeasureTime frame
kin anti-aging parameters, such as skin hydration, elasticity, lightness, dermal density, sagging, wrinkle and eyebag, are evaluated at baseline, 4 weeks and 8 weeks after treatment.

Secondary

MeasureTime frame
Assessment of self-questionnaires

Countries

Asia(except Japan)

Contacts

Public ContactTakeshi Katayoshi

DHC Corporation Primary Research Unit Primary Research Group 1

t-katayoshi@dhc.co.jp043-275-4811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026